Enfortumab Vedotin and the Evolving Landscape of Bladder Cancer Care: A Pharmacist’s Guide to ADCs, Combination Therapy, and Expanding Clinical Engagement

This MEDCast is dedicated to empowering pharmacists to play a more proactive and integrated role in the evolving management of bladder cancer, particularly as therapies such as enfortumab vedotin and antibody-drug conjugates reshape treatment paradigms across oncology practice. Through expert-driven discussions on patient identification, adverse event management, adherence, multidisciplinary collaboration, and real-world implementation, the series aims to equip pharmacy professionals with the clinical knowledge and practical strategies needed to improve treatment access, optimize safety, and enhance outcomes for patients with bladder cancer.